The Tampa-born chain took vein care out of the hospital, standardized it in neighborhood clinics and expanded into a national vascular platform. Its most useful lesson is operational, not medical - make specialized care local, repeatable and easy to understand, while treating price clarity as part of the product.
Center for Vein Restoration turned an overlooked corner of medicine into a national outpatient network. Its playbook is less about a miracle device than a repeatable system: specialist doctors, local clinics, centralized support, and procedures that send patients home the same day.
InterVene, Inc. is a Redwood City, California vascular medical device company building catheter-based tools for severe venous disease. Born out of Stanford Biodesign, it first pioneered BlueLeaf, a non-implantable system that forms new vein valves from a patient's own tissue, then pivoted its lead product to Recana, an FDA-cleared thrombectomy catheter system that clears venous in-stent restenosis and native-vessel obstructions - a stubborn problem that leaves stented patients with debilitating complications and few good options.